Linus Health to present new findings on accuracy and reliability of tech-enabled cognitive assessments BOSTON–(BUSINESS…
QuSecure Provides a More Easily Deployed Crypto-Agile Cybersecurity Solution Using Red Hat Open-Source Technologies SAN…
Combined company will operate as GRI Bio, Inc. and advance innovative pipeline of Natural Killer…
Honored for excellence in innovation in AI Assisted Medicine SAN FRANCISCO–(BUSINESS WIRE)–#ai–Viz.ai, the leader in…
NEW YORK & HONG KONG & SINGAPORE–(BUSINESS WIRE)–AMTD IDEA Group (“AMTD IDEA” or the “Company”,…
Collaboration Between cove.tool and Zauben to Drive Integration of Nature-Based Technologies into Built Environment ATLANTA–(BUSINESS…
Linus Health to present new findings on accuracy and reliability of tech-enabled cognitive assessments BOSTON–(BUSINESS…
Data accepted as AAN Late-Breaking Abstract THE WOODLANDS Texas, April 21, 2023 (GLOBE NEWSWIRE) —…
WATERTOWN, Mass., April 21, 2023 (GLOBE NEWSWIRE) — Disc Medicine, Inc. (NASDAQ:IRON), a clinical-stage biopharmaceutical…
The application is for a novel psychedelic-based combination, of Clearmind’s MEAI and SciSparc’s Cannamide™ Tel…
The application refers to a novel psychedelic-based combination of Clearmind’s MEAI and SciSparc’s Cannamide™ TEL AVIV, Israel,…
SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
SOUTH SAN FRANCISCO, Calif., April 21, 2023 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
NEWARK, Calif., April 21, 2023 (GLOBE NEWSWIRE) — CymaBay Therapeutics, Inc. (NASDAQ: CBAY), a biopharmaceutical…
Seasoned operating executive with successful track record at late-stage biopharmaceutical companies FARMINGTON HILLS, Mich., April…
SHANGHAI, China and PRINCETON, N.J., April 21, 2023 (GLOBE NEWSWIRE) — LianBio (Nasdaq: LIAN), a…
Applications are under review in Canada, Australia, the United Kingdom, and Switzerland Approval decisions expected…
TORONTO, April 21, 2023 (GLOBE NEWSWIRE) — Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos”…
LONDON, April 21, 2023 (GLOBE NEWSWIRE) — Freeline Therapeutics Holdings plc (Nasdaq: FRLN) today announced…
CALGARY, Alberta, April 21, 2023 (GLOBE NEWSWIRE) — XORTX Therapeutics Inc. (“XORTX” or the “Company”)…